CENBEXUS
DEAD

Serial Number

88882825

Owner

Celgene Corporation

Attorney

Xiomara Triana

Filing Date

Apr 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CENBEXUS Trademark

Serial Number: 88882825

CENBEXUS is a trademark filed by Celgene Corporation on April 22, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

April 22, 2020

Registration Date

Not Registered

Published for Opposition

July 6, 2021

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 7, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 7, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jan 31, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 30, 2024 AITU
SOU EXTENSION 5 FILED
Jan 12, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 4, 2023 EXRA
SOU EXTENSION 4 GRANTED
Aug 2, 2023 EX4G
SOU EXTENSION 4 FILED
Aug 2, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 2, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2023 EXRA
SOU EXTENSION 3 GRANTED
Feb 13, 2023 EX3G
SOU EXTENSION 3 FILED
Feb 13, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 29, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jul 27, 2022 EX2G
SOU EXTENSION 2 FILED
Jul 27, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 27, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 22, 2022 EXRA
SOU EXTENSION 1 GRANTED
Feb 18, 2022 EX1G
SOU EXTENSION 1 FILED
Feb 18, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 18, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 31, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 6, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 16, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2021 CRFA
ASSIGNED TO LIE
May 3, 2021 ALIE
NOTICE OF REVIVAL - E-MAILED
Jan 19, 2021 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 19, 2021 TROA
PETITION TO REVIVE-GRANTED
Jan 19, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 19, 2021 PROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 14, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2020 NWOS
NEW APPLICATION ENTERED
Apr 25, 2020 NWAP